PROPANC BIOPHARMA, INC. Stock Issued During Period, Shares, Conversion of Convertible Securities
PROPANC BIOPHARMA, INC. (PPCB) reported Stock Issued During Period, Shares, Conversion of Convertible Securities of 51.00 thousand shares for the 2-month period ending 2025-03-05, per its 10-Q filed 2025-05-15.
Financial Statements › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities · last filed 2026-07-17
- 2025-03-05: Stock Issued During Period, Shares, Conversion of Convertible Securities 2.04K shares; Stock Issued During Period, Shares, Conversion of Convertible Securities as first filed 51.00K shares.
- 2025-01-05: Stock Issued During Period, Shares, Conversion of Convertible Securities 2.04K shares; Stock Issued During Period, Shares, Conversion of Convertible Securities as first filed 51.00K shares.
- 2014-12-26: Stock Issued During Period, Shares, Conversion of Convertible Securities 1 month 5.66M shares.
- 2014-12-16: Stock Issued During Period, Shares, Conversion of Convertible Securities 0 month 5.19M shares.
| Period end | Stock Issued During Period, Shares, Conversion of Convertible Securities | Stock Issued During Period, Shares, Conversion of Convertible Securities as first filed | Stock Issued During Period, Shares, Conversion of Convertible Securities 0 month | Stock Issued During Period, Shares, Conversion of Convertible Securities 1 month | Stock Issued During Period, Shares, Conversion of Convertible Securities 2 month |
|---|---|---|---|---|---|
| 2025-03-05 | 2.04K shares S-1 · filed 2026-07-17 | 51.00K shares 10-K · filed 2025-09-29 | 51.00K shares 10-Q · filed 2025-05-15 | ||
| 2025-01-05 | 2.04K shares S-1 · filed 2026-07-17 | 51.00K shares 10-K · filed 2025-09-29 | |||
| 2014-12-26 | 5.66M shares 10-Q · filed 2015-02-17 | ||||
| 2014-12-16 | 5.19M shares 10-Q · filed 2015-02-17 | ||||
| 2014-11-04 | 8.16M shares 10-Q · filed 2015-02-17 | ||||
| 2014-09-11 | 7.43M shares 10-Q · filed 2015-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |